We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELC icon
4351
Celcuity
CELC
$4.27B
$14K ﹤0.01%
1,571
-10,164
-87% -$106K
EVI icon
4352
EVI Industries
EVI
$188M
$14K ﹤0.01%
754
-6,181
-89% -$135K
FLNT
4353
Fluent
FLNT
$104M
$14K ﹤0.01%
1,173
-7,597
-87% -$77.5K
IMDX
4354
Insight Molecular Diagnostics
IMDX
$149M
$14K ﹤0.01%
488
-3,164
-87% -$101K
RGS icon
4355
Regis Corp
RGS
$68.5M
$14K ﹤0.01%
347
-2,245
-87% -$78.3K
SAND
4356
DELISTED
Sandstorm Gold
SAND
$14K ﹤0.01%
1,751
-107
-6% -$738
SKYT icon
4357
SkyWater Technology
SKYT
$1.6B
$14K ﹤0.01%
+1,357
New +$14.9K
WVE icon
4358
Wave Life Sciences
WVE
$1.11B
$14K ﹤0.01%
7,381
-46,350
-86% -$114K
XFOR icon
4359
X4 Pharmaceuticals
XFOR
$377M
$14K ﹤0.01%
260
BODI icon
4360
The Beachbody Company
BODI
$72.3M
$14K ﹤0.01%
+124
New +$12.6K
TRVN
4361
DELISTED
Trevena, Inc.
TRVN
$14K ﹤0.01%
42
-276
-87% -$87.1K
EXPR
4362
DELISTED
Express, Inc.
EXPR
$14K ﹤0.01%
188
-66
-26% -$4.84K
EBET
4363
DELISTED
EBET, INC. Common Stock
EBET
$14K ﹤0.01%
+72
New +$22.4K
SDACW
4364
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$14K ﹤0.01%
+46,038
New +$17.9K
LHDX
4365
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$14K ﹤0.01%
+4,016
New +$19.7K
VZIO
4366
DELISTED
VIZIO Holding Corp.
VZIO
$14K ﹤0.01%
+1,476
New +$19.7K
CLNN icon
4367
Clene
CLNN
$64.4M
$13K ﹤0.01%
+166
New +$10K
CURE icon
4368
Direxion Daily Healthcare Bull 3X ETF
CURE
$181M
$13K ﹤0.01%
+100
New +$11.9K
DRIO icon
4369
DarioHealth
DRIO
$70.2M
$13K ﹤0.01%
+109
New +$18K
EEX
4370
DELISTED
Emerald Holding
EEX
$13K ﹤0.01%
+3,828
New +$13.4K
GLSI icon
4371
Greenwich LifeSciences
GLSI
$206M
$13K ﹤0.01%
+665
New +$13.4K
GNPX icon
4372
Genprex
GNPX
$3.06M
0
RYAN icon
4373
Ryan Specialty Holdings
RYAN
$5.71B
$13K ﹤0.01%
+330
New +$12.5K
TARA icon
4374
Protara Therapeutics
TARA
$227M
$13K ﹤0.01%
+2,510
New +$13.2K
WFRD icon
4375
Weatherford International
WFRD
$6.07B
$13K ﹤0.01%
+372
New +$11.7K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.